The report "Burn Care Market by Product (Advanced (Collagen, Film, Hydrogel, Foam, Alginate Dressings), Therapy Devices (Debridement, NPWT), Biologics, Traditional), Burn Degree (First, Second, Third-degree Burns), End User (Hospitals, ASCs) - Global Forecast to 2030", is valued at an estimated USD 2.55 billion in 2025 and is projected to reach USD 3.35 billion by 2030, at a CAGR of 5.6% during the forecast period.
Browse 345 market data Tables and 54 Figures spread through 302 Pages and in-depth TOC on "Burn Care Market by Product (Advanced (Collagen, Film, Hydrogel, Foam, Alginate Dressings), Therapy Devices (Debridement, NPWT), Biologics, Traditional), Burn Degree (First, Second, Third-degree Burns), End User (Hospitals, ASCs) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/burn-care-market-247121470.html
The burn care market is experiencing steady growth due to several key factors. One of the primary drivers is the increasing prevalence of burn injuries worldwide. Another important factor is innovation, particularly improvements in treatment technologies such as advanced burn dressings, biologics, and burn wound therapy devices. Additionally, the rising use of burn wound therapy devices has expanded treatment options, particularly for severe and complicated burns. Furthermore, supportive government initiatives and greater public awareness about burn prevention promote early intervention. Together, these factors are fueling strong demand and contributing to the ongoing growth of the global burn care market.
The biologics segment is expected to register the highest CAGR during the forecast period.
Based on products, the burn care market is categorized into five segments: advanced burn dressings, burn wound therapy devices, biologics, traditional burn care products, and other burn care products. Among these, the biologics segment is expected to register the highest CAGR during the forecast period. This growth is driven by the rising demand for advanced and effective treatment options for deep and complex burns. Biologics provide targeted healing, minimize long-term complications, and promote tissue regeneration, making them particularly suitable for treating severe burns. The increasing acceptance of these products among healthcare professionals and ongoing innovations in regenerative medicine are contributing to the strong and sustained growth of the biologics segment.
The second-degree burns (partial-thickness burns) segment dominated the burn care market, by burn degree, in 2024.
Based on burn degree, the burn care market is divided into first-degree burns (minor burns), second-degree burns (partial-thickness burns), and third-degree burns (full-thickness burns). Of these, the second-degree burns segment accounted for the largest market share of the burn care market in 2024. This is largely because partial-thickness burns occur more frequently. These burns tend to destroy the epidermis and dermis; as such, they require the application of advanced burn care products, which drives consistent demand in this segment.
North America is the largest regional market for burn care products.
The market for burn care is divided into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the burn care market in 2024 with the largest market share. This is primarily because countries like the US and Canada have well-developed healthcare facilities, supporting widespread access to advanced burn care products and treatments. The region also experiences a high rate of burn injuries. The availability of key players and constant investment in research & development further consolidate North America's position in the burn care market.
The major players operating in this market are Smith+Nephew (UK), Mölnlycke Health Care AB (Sweden), Cardinal Health Inc. (US), Integra LifeSciences Holdings Corporation (US), ConvaTec Group Plc (UK), Coloplast Group (Denmark), Solventum Corporation (US), Essity Aktiebolag (Sweden), PAUL HARTMANN AG (Germany), and Organogenesis Holdings Inc. (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/